Concept explainers
Cervical Cancer Incidence In HPV-Positive Women In 2003, Michelle Khan and her coworkers published their findings on a 10-year study in which they followed cervical cancer incidence and HPV status in 20,514 women. All women who participated in the study were free of cervical cancer when the test began. Pap tests were taken at regular intervals, and the researchers used a DMA probe hybridization test (Section 15.3) to detect specific types of HPV in the women's cervical cells.
The results are shown in FIGURE 37.26 as a graph of the incidence rate of cervical cancer by HPV type. HPV- positive women are often infected by more than one type, so the data were sorted into groups based on the women's HPV status ranked by type: either positive for HPV16; or negative for HPV16 and positive for HPV18; or negative for HPV16 and HPV18 and positive for any other cancer-causing HPV; or negative for all cancer-causing HPV.
Follow-up time (months)
FIGURE 37.26 Cumulative incidence rate of cervical cancer correlated with HPV status in, 20,514 women aged 16 years and cider.
The data were grouped as follows:
● HPV16 positive
○ HFV16 negative and HPV18 positive
▼ All other cancer-causing HPV Types combined
∇ No cancer-causing HPV type was detected.
3. Is it possible to estimate from this graph the overall risk of cervical cancer that is associated with infection of cancer-causing HPV of any type?
Want to see the full answer?
Check out a sample textbook solutionChapter 37 Solutions
MindTap Biology, 1 term (6 months) Printed Access Card for Starr/Taggart/Evers/Starr's Biology: The Unity and Diversity of Life (MindTap Course List)
- Cervical Cancer Incidence In HPV-Positive Women In 2003, Michelle Khan and her coworkers published their findings on a 10-year study in which they followed cervical cancer incidence and HPV status in 20,514 women. All women who participated in the study were free of cervical cancer when the test began. Pap tests were taken at regular intervals, and the researchers used a DMA probe hybridization test (Section 15.3) to detect specific types of HPV in the women's cervical cells. The results are shown in FIGURE 37.26 as a graph of the incidence rate of cervical cancer by HPV type. HPV- positive women are often infected by more than one type, so the data were sorted into groups based on the women's HPV status ranked by type: either positive for HPV16; or negative for HPV16 and positive for HPV18; or negative for HPV16 and HPV18 and positive for any other cancer-causing HPV; or negative for all cancer-causing HPV. Follow-up time (months) FIGURE 37.26 Cumulative incidence rate of cervical cancer correlated with HPV status in, 20,514 women aged 16 years and cider. The data were grouped as follows: HPV16 positive HFV16 negative and HPV18 positive All other cancer-causing HPV Types combined No cancer-causing HPV type was detected. 2. In which group would women infected with both HPV16 and HPV18 fall?arrow_forwardCervical Cancer Incidence In HPV-Positive Women In 2003, Michelle Khan and her coworkers published their findings on a 10-year study in which they followed cervical cancer incidence and HPV status in 20,514 women. All women who participated in the study were free of cervical cancer when the test began. Pap tests were taken at regular intervals, and the researchers used a DMA probe hybridization test (Section 15.3) to detect specific types of HPV in the women's cervical cells. The results are shown in FIGURE 37.26 as a graph of the incidence rate of cervical cancer by HPV type. HPV- positive women are often infected by more than one type, so the data were sorted into groups based on the women's HPV status ranked by type: either positive for HPV16; or negative for HPV16 and positive for HPV18; or negative for HPV16 and HPV18 and positive for any other cancer-causing HPV; or negative for all cancer-causing HPV. Follow-up time (months) FIGURE 37.26 Cumulative incidence rate of cervical cancer correlated with HPV status in, 20,514 women aged 16 years and cider. The data were grouped as follows: HPV16 positive HFV16 negative and HPV18 positive All other cancer-causing HPV Types combined No cancer-causing HPV type was detected. 1. At 110 months into the study, what percentage of women who were not infected with any type of cancer-causing HPV had cervical cancer? What percentage of women who were infected with HPV16 also had cervical cancer?arrow_forwardTrue/False with Justification. Indicate whether the statement is true or false. Then, regardless of whether you choose true or false, explain your reasoning. The Wee1 kinase could be considered the product of a tumor suppressor gene. A cell containing a mutant form of the Rb protein that cannot be phosphorylated would be blocked at the G1 -> S checkpoint.arrow_forward
- Introductin of infectious agents and oncogenesis. Identify at least five infectious agent that play role in oncogenesis and for each infectious agent write what cancer is associated with its development and its mechanism of oncogenesis?arrow_forwardMM, a 54-year old female presents to the Family Medicine Clinic due to a 2-week history of increasing shortness of breath and cough and mild/moderate pain in left side. She was diagnosed with infiltrating intraductal adenocarcinoma of the left breast 5 years ago; at that time, ER(-)/ PR(-); her-2/neu(+); p53(+); staged as having T3N1M0, stage IIIA, high-risk breast cancer. She underwent a modified radical mastectomy with axillary node dissection followed by 6 cycles of CMF chemotherapy. Her mother and sister also had a history of breast cancer. Past Medical History Gravida 4, para 4; menses onset age 13; HTN x 10 years; Type 2 DM x 8 years; breast CA described above; remained disease free until present follow up. Past Surgical History: Left modified radical mastectomy 5 years ago; cholecystectomy 14 years ago. Medications: Glyburide, 5mg PO BID Verapamil SR, 240mg PO daily Furosemide, 40mg PO daily Allergies: NKDA Physical Examination: GEN: Well-developed, obese woman in no…arrow_forwardTrue or False? p21 inhibits the S-cyclin/S-Cdk complex.arrow_forward
- The head of the oncology divison of a large biotech company proposes to develop a therapeutic antibody to treat cancers with mutant B-Raf oncogene. Is this a good idea? Why or why not(limit 3-4 sentences)?arrow_forwardEffects of BPA on proinflammatory cytokines generation in RAW264.7 cells conclusionarrow_forwardThe product of the human papillomavirous oncogene E7promotes cancer by emhancing expression of telomere inhibiting DNA damage repair pathways binding to Rb protein and preventing itd function ubiquitinating the tumor suppressor p53arrow_forward
- Ataxia-telangiectasis (ATM) is a rare genetic neurodegenerative disease. About 20% of people with ATM develop acute lymphocytic leukemia or lymphoma, cancers of the immune-system cells. Cells in many of these cancers exhibit chromosome rearrangements, with chromosome breaks occurring at antibody and T-cell-receptor genes (A. L. Bredemeyer et al. 2006. Nature 442:466–470). Many people with ATM also have a weakened immune system, which makes them susceptible to respiratory infections. Research has shown that the locus that causes ATM has a role in the repair of double-strand breaks. Explain why people who have a genetic defect in the repair of doublestrand breaks might have a high incidence of chromosome rearrangements in their immune-system cells and why their immune systems might be weakened.arrow_forwardCASE STUDY Cancer-killing bacteria Ralph, a 57-year-old man, was diagnosed with colon cancer.His oncologist discussed the use of radiation andchemotherapy as treatments, both of which can causedebilitating side effects. Ralph decided to explore other optionsand went to a cancer clinic. He learned that researchers in asynthetic biology program were testing the use of geneticallymodified bacterial cells designed to selectively invade specifictumors and kill cancer cells, with no effects on normal cells.Ralph decided to participate and was informed that he wouldbe part of a phase III trial, comparing the effects of the modifiedbacterial cell treatment against conventional chemotherapy.However, as part of the trial, he would be randomly assigned toreceive one or the other treatment. He was disappointed to learnthis, because he assumed that he would receive the bacterialtherapy.Question: Informed consent is legally and ethically required beforesomeone participates in a clinical trial.…arrow_forwardOut of these 8 hallmarks ( sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, activating invasion and metastasis, deregulating cellular energetics and metabolism, and avoiding immune destruction). Rank them from least important to most for cancer development. Explain in 2-3 sentences how.arrow_forward
- Biology: The Unity and Diversity of Life (MindTap...BiologyISBN:9781305073951Author:Cecie Starr, Ralph Taggart, Christine Evers, Lisa StarrPublisher:Cengage LearningBiology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage Learning